Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-21

Clinical Trial Update: GSK1521498 Alcohol Interaction Study [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating alcohol interaction with GSK1521498 in individuals with alcohol use disorder; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK1521498 (GSK1521498)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alcoholism | Phase 1 | Status: COMPLETED